Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.
NCT05142709
·
clinicaltrials.gov ↗
COMPLETED
Status
1197
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Esophageal Squamous Cell Carcinoma
Interventions
DRUG:
Anti-PD-1 Immune Checkpoint Inhibitors
Sponsor
Fudan University